Xcout Intel
GENEOS Therapeutics, Inc.
GENEOS Therapeutics, Inc. is a biotechnology company focused on developing exquisitely personalized, EPIC-based cancer immunotherapies. The company is headquartered in Philadelphia, Pennsylvania, United States.
Subscribe to see GENEOS Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
GENEOS Therapeutics, Inc. at a glance
GENEOS Therapeutics, Inc. is a healthcare company headquartered in United States. Its most recent funding round, Series A3, raised $5M in September 2023. Xcout tracks 10 named people at GENEOS Therapeutics, Inc., including Greg Hamilton (President, Brightstar; CIO, Americo).
GENEOS Therapeutics, Inc. leadership
- Greg HamiltonPresident, Brightstar; CIO, Americo
- Dennis WalshCFO, Americo
- Casey CunninghamChief Scientific Officer, Santé Ventures
- Laurent HumeauChief Scientific Officer, Inovio Pharmaceuticals
- Niranjan Y. SardesaiFounder, President & CEO
- David B. WeinerW.W. Smith Endowed Chair in Cancer Research, The Wistar Institute
4 more named people on record for GENEOS Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
GENEOS Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A3 | $5M | 2 named | |
| SEC Form D filing | $17.2M | — | |
| SEC Form D filing | $10.4M | — | |
| SEC Form D filing | $4.5M | — | |
| Series A | $10.5M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
GENEOS Therapeutics, Inc. competitors
A few of GENEOS Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
GEMMABio is a privately held therapeutics company founded in 2024 in Philadelphia, Pennsylvania, dedicated to developing novel gene therapies for rare diseases.
GEn1E Lifesciences Inc. is a clinical-stage, Phase 2 biotechnology research company based in Palo Alto, California, focused on accelerating novel precision therapies.
Infinitopes is a biotechnology research company based in Oxford, United Kingdom, focused on developing revolutionary off-the-shelf precision vaccines to prevent deaths from cancer metastases.
Gritstone bio, Inc. is a clinical-stage biotechnology company headquartered in Emeryville, California. The firm engages in developing next-generation cancer immunotherapies and vaccines to fight various forms of cancer and infectious diseases.
Century Therapeutics is an innovative biotechnology company headquartered in Philadelphia, Pennsylvania. Its mission is to develop allogeneic, iPSC-derived NK and T cell therapies that are designed to be more effective, tolerable, and accessible.
Code Biotherapeutics, Inc. is a biotechnology company headquartered in the Greater Philadelphia area. The firm focuses on next-generation gene therapies and advanced medicine.
Get GENEOS Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on GENEOS Therapeutics, Inc. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access